17th EBF Open Symposium

Share this event:

The event has passed.

Start Date

November 20

End Date

November 22

City

Barcelona

“Taking the temperature of Bioanalysis”

Join us at EBF 2024

Booth B9

 

Our Presentations

Day 1 – Wednesday 20 November

Rebecca Sleigh
15:20–15:40, Session 4
Agile development and Risk-Based validation of bespoke LIMS – Laboratory innovation in a post GAMP 5 Second Edition era

Day 2 – Thursday 21 November

Laura Geary
09:20–09:40, Session 8
Evaluating the Tiered Approach in an ADA Gene Therapy Assay

Ashley Phillips
10:00–10:20, Session 9a
Upstream without a PAD-dle: Challenges and their Resolution in the Development of a Hybrid LC-MS Assay for PAD2 and PAD4

Teona Roschupkina
15:10–15:30, Session 14
Stabilizing Flow: Overcoming Logistics Challenge by ‘Split Processing’

Daniel Creed
17:20–17:40, Session 16
Overcoming the Hurdles of a PAD Enzymatic Endpoint Assay: A Demanding Development”

Day 3 – Friday 22 November

Aihua Liu
09:40–10:00, Session 18a
The Challenges and Solutions in Developing Ultra-Sensitive Bioanalytical Assays for Oligonucleotide Therapeutics Using a Hybridization LCMS Platform

Venue Details

EBF, Hyatt Regency Barcelona Tower, Gran Via 144, L’Hospitalet de Llobregat
Barcelona, 08907 Spain

Events Details

Time :
All day
Categories :

Add to Calendar

+ Google Calendar
+ ICal Export
+ Outlook

More Events

There are no related events

For the latest news, visit our LinkedIn

Visit LinkedIn

Visit our Events page

Visit Events

Copyright © 2024 Resolian Inc. All rights reserved.

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Linkedin

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Linkedin

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now Chief Business Officer at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.